An interventional study of DidgeriTU and Sham device in OSA and Obstructive Sleep Apnea, sponsored by Thammasat University Hospital. Recruiting at 1 site in Thailand. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-01-21.
Sponsored by Thammasat University Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 15 studies in Sleep Apnea, Obstructive with a site in Thailand — 4 open to participants now, 4 under way, none of them phase 3. Sleep Apnea, Obstructive · Thailand.
Among the 15 studies in Sleep Apnea, Obstructive with a site in Thailand, this one is the 3rd largest by planned enrollment of the 12 interventional ones that give a count, is one of 2 that started in 2025, is one of 10 with no phase, and was the 11th registered.
2,246 studies on the registry are indexed under Sleep Apnea, Obstructive; 476 are open to participants now.
Browse Sleep Apnea, Obstructive studies →4 of the 15 studies in Sleep Apnea, Obstructive with a site in Thailand are open now. Recruiting first, the newest first:
Thammasat University · Sites in Thailand
Ages 18+
Chulalongkorn University · Sites in Thailand
Ages 18–65
Ramathibodi Hospital · Sites in Thailand
Ages 19+
A study can be open while its sites in Thailand have not opened yet or have stopped. Only those recruiting at a site in Thailand →
Of the 317 Sleep Apnea, Obstructive studies recruiting now, 149 (47%) set no upper age limit and 124 (39%) stop at 75 or younger; 53 take children under 18; 66 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 2 started in 2025.
This study's planned enrollment of 76 is above the median of 52 across 1,476 interventional studies indexed under Sleep Apnea, Obstructive.
Median enrollment 36 across the 12 interventional studies, 150 across the 3 observational. Of the 8 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 15 has an industry lead sponsor. The 6 most frequent:
Thammasat University Hospital is the lead sponsor of 16 studies on the registry; 7 are open to participants now.
Thammasat University Hospital has 2 studies filed under Sleep Apnea, Obstructive — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 15 studies in Sleep Apnea, Obstructive with a site in Thailand, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to test for the efficacy of the newly invented device #DidgeriTU with non-severe obstructive sleep apnea. The main question it aims to answer is:
Participants will:
Previously, in Switzerland, an aboriginal musical instrument, the Didgeridoo, was taught to patients with OSA. It has been proven to be effective in reducing apnea events.
Our newly invented instrument, DidgeriTU, adopts the Didgeridoo principle for expiratory muscle exercise to reduce apnea events.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
patients with non severe OSA using DidgeriTU device
Device: DidgeriTU
Patients with non severe OSA receive a device that look alike didgeriTU but without resistance plate
Device: Sham device
the study device that immitate the principle of didgeridoo for expiratory muscle exercise
a device that look alike DidgeriTU but without resistance plate
Change of apnea event after DidgeriTU usage compared with sham device
Participants with a known history of non-severe obstructive sleep apnea will repeat the home sleep apnea test. The study will include patients with non-severe OSA(Apnea-hypopnea index 5-29/hr) from HSAT. After the usage of DidgeriTU or sham device for 3 months, the participant will repeat HSAT to explore the change of AHI after DidgeriTU use compared with sham device.
Time frame: 3 months
Change of OSA severity after the usage of DidgeriTU comparing with sham device
Participants with a known history of non-severe obstructive sleep apnea will repeat the home sleep apnea test. The study will include patients with non-severe OSA(Apnea-hypopnea index 5-29/hr.) from HSAT and categorize patients with AHI 5-14/hr as mild OSA, AHI 15-29/hr as moderate OSA. After the usage of DidgeriTU or sham device for 3 months, the participant will repeat HSAT to explore the change of OSA severity after DidgeriTU use compared with sham device.
Time frame: 3 months
Change in Epworth sleepiness scale after the usage of DidgeriTU comparing with sham device
The participants' daytime sleepiness will be evaluated at the beginning of the study by the Thai version of the Epworth sleepiness scale then followed up with an online questionnaire every month until the end of the study. The total ESS score ranges from 0 to 24, with higher scores indicating greater daytime sleepiness. The change in ESS in patients using DidgeriTU will be compared with patients using sham devices.
Time frame: 3 months
Change of maximum inspiratory pressure; MIP after DidgeriTU usage comparing with sham device
The participants' maximum inspiratory pressure; MIP will be measured at the beginning and end of the study to compare the effect of DidgeriTU and sham device with inspiratory muscle which will be reported in cmH2O.
Time frame: 3 months
Change of maximum expiratory mouth pressure; MEP after DidgeriTU usage comparing with sham device
The participants' maximum expiratory mouth pressure; MEP will be measured at the beginning and end of the study to compare the effect of DidgeriTU and sham device with expiratory muscle which will be reported in cmH2O.
Time frame: 3 months
change in Pittsburg Sleep Quality Index; PSQI after DidgeriTU usage comparing with sham device
The participants' sleep quality will be evaluated at the beginning of the study by the Thai version of the Pittsburg sleep quality index then followed up with an online questionnaire every month until the end of the study. The global PSQI score ranges from 0 to 21, where lower scores indicate better sleep quality. The change in PSQI in patients using DidgeriTU will be compared with patients using sham devices.
Time frame: 3 months
Change of snoring frequency after DidgeriTU usage compared with a sham device
The snoring index (events/hour) will be recorded from HSAT at the beginning and end of the study. The change of snoring index from patients using DidgeriTU and sham device will be compared.
Time frame: 3 months
change of oxygenation during sleep after DidgeriTU usage comparing with sham device
The average oxygen saturation (%) will be recorded from HSAT at the beginning and end of the study. The change in average oxygen saturation from patients using DidgeriTU and sham device will be compared.
Time frame: 3 months
Plan to share: No
No publications or documents are linked to this record.
Started May 2025 (actual). Primary completion is estimated for Mar 2026, 10 months after the start.
Of 511 non-industry interventional studies with no phase under Sleep Apnea, Obstructive, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's planned 10 months is below that.
Counting every sponsor, half of 629 studies reached it within 27 months; a quarter within 12 and three quarters within 50.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Thammasat University Hospital